Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > News > Leading Scientists to Present Computational and Informatics Solutions at Accelrys Science Forum Series

October 8th, 2007

Leading Scientists to Present Computational and Informatics Solutions at Accelrys Science Forum Series

Abstract:
Innovative science and technology will be the focus of a major seminar series by Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific modeling and workflow software solutions. The seminar series will provide a look at the most recent developments in modeling and simulation, informatics and data integration analysis and reporting and will feature presentations by scientists from industry, academia and Accelrys. The event is free for registrants and will be held at locations throughout the US and Europe.

The seminar features tracks for Pharmaceutical and Biotechnology Research, Chemicals and Materials R&D, and Platform, Informatics, and Reporting. Topics in the Pharmaceutical and Biotechnology track include rational flexible docking, QM/MM, pk predictions for proteins, antibody modeling and docking, and de novo fragment-based design. In the Chemicals/Materials track topics include catalysis, nanotechnology, crystallization, and QSAR. Topics in the Platform and Informatics track include enterprise and desktop cheminformatics solutions, reporting and drill-down dashboards, high content analysis, and web service & application development within an SOA environment.

Source:
pharmalive.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Gold nanoparticles to facilitate in-situ detection of amplified DNA at room temperature March 21st, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia March 11th, 2019

New optical imaging system could be deployed to find tiny tumors: Near-infrared technology pinpoints fluorescent probes deep within living tissue; may be used to detect cancer earlier March 8th, 2019

Announcements

Dynamic hydrogel used to make 'soft robot' components and LEGO-like building blocks March 22nd, 2019

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Organic semiconductors: One transistor for all purposes March 22nd, 2019

Making solar cells is like buttering bread March 22nd, 2019

Events/Classes

Lightweight metal foams become bone hard and explosion proof after being nanocoated March 14th, 2019

NSS Congratulates SpaceX and NASA on Docking Dragon 2 Spacecraft to International Space Station: A historic milestone in commercial space was achieved on March 3 March 7th, 2019

Exchanging information securely using quantum communication in future fiber-optic networks: New research demonstrates potential solutions as transmission networks evolve to use multicore fiber March 6th, 2019

AIM Photonics Attends OFC 2019—the Optical Networking and Communication Conference & Exhibition to Share World-Class Capabilities and Partnership Opportunity Updates February 28th, 2019

Nanobiotechnology

Discovery may lead to precision-based strategy for triple negative breast cancer: Indiana University researcher develops promising nanotechnology approach for treatment of aggressive form of disease March 22nd, 2019

Gold nanoparticles to facilitate in-situ detection of amplified DNA at room temperature March 21st, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia March 11th, 2019

Computer-designed vaccine elicits potent antibodies against RSV: The nanoparticle platform for this respiratory syncytial virus study will be applied to vaccine research on flu, HIV, and more; Seattle startup Icosavax will advance related clinical trials March 8th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project